The study's primary objectives are the
- Comparison of viremia levels after yellow fever vaccination in travelers under low dose methotrexate therapy (≤20mg/ /week) and healthy travelers at short intervals after vaccination
- Comparison of yellow fever specific antibody levels after yellow fever vaccination in travelers under low dose methotrexate therapy (≤20mg/week) and healthy travelers at short intervals after vaccination
Secondary objectives
- Comparison of the percentage of individuals who develop quantitative antibody levels >0.7 LNI (>0.5 IU/ml) in both groups at short intervals after vaccination
- Safety assessment of yellow fever vaccination in both groups by studying adverse vaccine reactions
For more information and to participate please visit the project page.